A Northwestern University analysis published March 18 in JAMA Cardiology found that natural menopause before age 40 is associated with roughly a 40% higher lifetime risk of coronary heart disease (including heart attack and fatal coronary disease). The study pooled data from more than 10,000 postmenopausal women drawn from six major U.S. population-based studies spanning 1964–2018.
Premature menopause—defined as ovarian function ending and periods stopping before age 40—appears to be more common than older estimates suggested. The researchers estimated that 3–4% of women experience premature natural menopause, higher than prior estimates of about 1% for overt cases. The analysis also revealed stark racial disparities: Black women experienced premature menopause at more than three times the rate of white women (15.5% vs. 4.8%). While the roughly 40% increase in heart disease risk applied across racial groups, the higher prevalence among Black women means a larger population-level burden. The study calculated that Black women with premature menopause averaged 18.2 years free of heart disease after age 55, compared with 19.1 years for Black women whose menopause occurred at typical ages.
Researchers and clinicians point to the early loss of estrogen as a likely driver of the increased cardiovascular risk. When estrogen declines earlier than expected, it can set off metabolic and vascular changes—loss of muscle mass, gain of visceral (abdominal) fat, increased arterial stiffness, and rises in cholesterol and blood pressure—that create a more favorable environment for cardiovascular disease. Most cases of premature menopause have no single identifiable cause, though autoimmune conditions, infections, inflammatory disorders, and genetic mutations can play a role.
Rather than viewing premature menopause only as bad news, experts say it should signal an opportunity for earlier prevention. The years before and after menopause (perimenopause and early postmenopause) are a ‘‘window of opportunity’’ when blood pressure, lipids, glucose, and other risk factors often begin to change. Detecting and addressing these shifts sooner can yield lasting benefits.
Practical clinical steps recommended by the study and outside experts include routinely asking patients about the age periods stopped and whether menopause was natural or surgical, flagging women who reached menopause before 40 for more intensive risk assessment, and promptly evaluating blood pressure, cholesterol, blood sugar, weight, sleep, and smoking status. Clinicians should review pregnancy and family history, discuss exercise and diet, treat bothersome menopause symptoms, and consider more aggressive management of risk factors when appropriate.
Lifestyle strategies are central to reducing long-term cardiovascular risk: strength training at least twice weekly to preserve muscle and metabolism, regular aerobic activity, nutritious eating, good sleep, stress reduction, and routine screening for hypertension, high cholesterol, and diabetes. Addressing social determinants of health and chronic stress—often called ‘‘weathering’’—is also important, since caregiving burdens, financial strain, and limited access to care can accelerate biological aging and contribute to higher premature menopause rates.
Reproductive history, including the timing of menopause, should be part of cardiovascular risk assessment. Identifying premature menopause gives clinicians and patients a chance to intervene earlier with lifestyle measures, symptom management, and targeted screening or treatment to reduce future heart disease risk.
